4.5 Article

The development of vaccine viruses against pandemic A(H1N1) influenza

Journal

VACCINE
Volume 29, Issue 9, Pages 1836-1843

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.12.044

Keywords

Influenza vaccines; Candidate vaccine viruses; Reverse genetics; High growth reassortants; HA antigen yield

Ask authors/readers for more resources

Wild type human influenza viruses do not usually grow well in embryonated hens' eggs, the substrate of choice for the production of inactivated influenza vaccine, and vaccine viruses need to be developed specifically for this purpose. In the event of a pandemic of influenza, vaccine viruses need to be created with utmost speed. At the onset of the current A(H1N1) pandemic in April 2009, a network of laboratories began a race against time to develop suitable candidate vaccine viruses. Two approaches were followed, the classical reassortment approach and the more recent reverse genetics approach. This report describes the development and the characteristics of current pandemic H1N1 candidate vaccine viruses. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available